logo
  

Stratasys Board Rejects Proposal From Nano Dimension - Quick Facts

Stratasys Ltd. (SSYS) said its Board of Directors has unanimously rejected the
unsolicited proposal it received from Nano Dimension Ltd. (NNDM) to acquire Stratasys for $18.00 per share in cash. The Stratasys Board concluded that Nano's proposal substantially undervalues the company in light of its standalone prospects and is not in the best interests of Stratasys and its shareholders.

Stratasys said its Board and management team are confident that the company's standalone plan will create significantly greater value for its shareholders than the Nano proposal.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT